United Maritime Capital’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,255
Closed -$323K 64
2021
Q4
$323K Hold
2,255
0.37% 43
2021
Q3
$467K Sell
2,255
-100
-4% -$22K 0.52% 44
2021
Q2
$500K Hold
2,355
0.38% 45
2021
Q1
$427K Sell
2,355
-830
-26% -$165K 0.35% 46
2020
Q4
$355K Buy
+3,185
New +$339K 0.31% 43

Other funds holding NVAX

United Maritime Capital's NVAX Position: Q1 2022 in Review

United Maritime Capital sold out of Novavax (NVAX) in Q1 2022, closing a stake of 2,255 shares — an estimated $323K sold.

United Maritime Capital first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $500K in Q2 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • United Maritime Capital reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • United Maritime Capital sold 2,255 Novavax shares in Q1 2022, an estimated $323K.
  • United Maritime Capital first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
  • United Maritime Capital's Novavax position peaked at $500K in Q2 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on United Maritime Capital's 13F filing for Q1 2022, filed 12 May 2022.